Philip D. Stein

1.6k total citations
44 papers, 902 citations indexed

About

Philip D. Stein is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Philip D. Stein has authored 44 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Physiology. Recurrent topics in Philip D. Stein's work include Nitric Oxide and Endothelin Effects (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Receptor Mechanisms and Signaling (5 papers). Philip D. Stein is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Receptor Mechanisms and Signaling (5 papers). Philip D. Stein collaborates with scholars based in United States, Germany and Sweden. Philip D. Stein's co-authors include Alan P. Kozikowski, Eddie C.‐K. Liu, John T. Hunt, Suzanne Moreland, Maria L. Webb, David Floyd, Patricia M. Rose, Kenneth E.J. Dickinson, Natesan Murugesan and Mark C. Kowala and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Philip D. Stein

42 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip D. Stein United States	18	351	348	267	210	54	44	902
Lisa E. Hernandez United States	16	267 0.8×	134 0.4×	269 1.0×	118 0.6×	78 1.4×	25	856
Jeremy J. Edmunds United States	20	427 1.2×	631 1.8×	141 0.5×	142 0.7×	16 0.3×	54	1.1k
Steven A. Boyd United States	18	322 0.9×	320 0.9×	99 0.4×	71 0.3×	29 0.5×	34	739
William C. Patt United States	13	281 0.8×	510 1.5×	134 0.5×	73 0.3×	19 0.4×	23	804
Eddie C.‐K. Liu United States	16	275 0.8×	69 0.2×	295 1.1×	261 1.2×	38 0.7×	24	557
Stéphane De Lombaert United States	22	362 1.0×	599 1.7×	166 0.6×	138 0.7×	78 1.4×	49	1.2k
Alan Hruza United States	15	650 1.9×	212 0.6×	266 1.0×	64 0.3×	31 0.6×	23	1.2k
Anne‐Charlotte Le Monnier de Gouville France	8	349 1.0×	221 0.6×	180 0.7×	95 0.5×	46 0.9×	9	642
Robert A. Mantei United States	15	308 0.9×	258 0.7×	76 0.3×	61 0.3×	32 0.6×	24	621
Gerald J. Tanoury United States	17	232 0.7×	772 2.2×	250 0.9×	34 0.2×	37 0.7×	27	1.2k

Countries citing papers authored by Philip D. Stein

Since Specialization

Citations

This map shows the geographic impact of Philip D. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Stein more than expected).

Fields of papers citing papers by Philip D. Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Stein. The network helps show where Philip D. Stein may publish in the future.

Co-authorship network of co-authors of Philip D. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Stein. A scholar is included among the top collaborators of Philip D. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Stein. Philip D. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stroke, Ilana L., David W. Hilbert, Laurie J. Sturzenbecker, et al.. (2018). Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB). Bioorganic & Medicinal Chemistry Letters. 28(4). 756–761. 7 indexed citations

Stroke, Ilana L., David W. Hilbert, Andrew G. Cole, et al.. (2018). Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB). Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3601–3605. 8 indexed citations

Shi, Yan, Jing Zhang, Mengxiao Shi, et al.. (2009). Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4034–4041. 13 indexed citations

Shi, Yan, Chi Li, Stephen P. O’Connor, et al.. (2009). Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577. Bioorganic & Medicinal Chemistry Letters. 19(24). 6882–6889. 19 indexed citations

O’Connor, Stephen P., Karnail S. Atwal, Chi Li, et al.. (2008). Synthesis and evaluation of acylguanidine FXa inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4696–4699. 7 indexed citations

Shi, Yan, Doree Sitkoff, Jing Zhang, et al.. (2007). Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5952–5958. 9 indexed citations

Malley, Mary F., Andrew T. Pudzianowski, Hossain Monshizadegan, et al.. (2005). A switch in enantiomer preference between mitochondrial F1F0-ATPase chemotypes. Bioorganic & Medicinal Chemistry Letters. 15(11). 2749–2751. 7 indexed citations

Stein, Philip D.. (2004). Give Us Your Best. Quality progress. 37(5). 78–79.

Atwal, Karnail S., Saleem Ahmad, Charles Z. Ding, et al.. (2004). N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase. Bioorganic & Medicinal Chemistry Letters. 14(4). 1027–1030. 12 indexed citations

10.

Hamann, Lawrence G., Charles Z. Ding, Arthur V. Miller, et al.. (2004). Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase. Bioorganic & Medicinal Chemistry Letters. 14(4). 1031–1034. 23 indexed citations

11.

Ahmad, Saleem, John D. DiMarco, Mary Lee Conder, et al.. (2003). Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKs. Bioorganic & Medicinal Chemistry Letters. 14(1). 99–102. 11 indexed citations

12.

Murugesan, Natesan, Zhengxiang Gu, Philip D. Stein, et al.. (2002). Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3: Structure–Activity Relationship of 4′-Heterocyclic Biphenylsulfonamides. Bioorganic & Medicinal Chemistry Letters. 12(4). 517–520. 3 indexed citations

13.

Lloyd, John, George C. Rovnyak, Saleem Ahmad, et al.. (2001). Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable I_Ks Blockers. Journal of Medicinal Chemistry. 44(23). 3764–3767. 18 indexed citations

14.

Stein, Philip D., Jerald W. Henry, & Alexander Gottschalk. (1996). Small perfusion defects in suspected pulmonary embolism.. PubMed. 37(8). 1313–6. 7 indexed citations

15.

Webb, Maria L., Pramathesh S. Patel, Patricia M. Rose, et al.. (1996). Mutational Analysis of the Endothelin Type A Receptor (ET_A): Interactions and Model of the Selective ET_AAntagonist BMS-182874 with the Putative ET_AReceptor Binding Cavity. Biochemistry. 35(8). 2548–2556. 17 indexed citations

16.

Krystek, Stanley R., John T. Hunt, Philip D. Stein, & Terry R. Stouch. (1995). Three-Dimensional Quantitative Structure-Activity Relationships of Sulfonamide Endothelin Inhibitors. Journal of Medicinal Chemistry. 38(4). 659–668. 28 indexed citations

17.

Stein, Philip D., David Floyd, Jack Z. Gougoutas, et al.. (1995). Discovery and Structure-Activity Relationships of Sulfonamide ETA-Selective Antagonists. Journal of Medicinal Chemistry. 38(8). 1344–1354. 28 indexed citations

18.

Bird, J. Eileen, et al.. (1995). BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 272(3). 1124–1134. 35 indexed citations

19.

Kozikowski, Alan P. & Philip D. Stein. (1982). ChemInform Abstract: THE INOC ROUTE TO CARBOCYCLICS: A FORMAL TOTAL SYNTHESIS OF (.+‐.)‐SARKOMYCIN. Chemischer Informationsdienst. 13(43). 10 indexed citations

20.

Stein, Philip D., et al.. (1973). Modification of tetanus toxin with selective chemical reagents.. PubMed. 145(5). 418–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact